Pacific Biosciences Of California | PACB - Sales Revenues

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $39.97M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
Agilent USD 1.86B 123M Sep/2025
Bruker USD 977.2M 116.7M Dec/2025
Danaher USD 6.84B 790M Dec/2025
General Electric Aerospace USD 11.87B 560M Dec/2025
Illumina USD 1.16B 80M Dec/2025
Myriad Genetics USD 205.7M 7.4M Sep/2025
Pacific Biosciences Of California USD 39.97M 3.95M Sep/2024
Quidel USD 724M 24M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Standard Biotools USD 19.55M 2.21M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 932M 132M Dec/2025